2reverse splits
1-for-894 cumulative
+294.8%share growth, 1-year
XBRL EDGAR
212.7M → 50.9Bshares issued (XBRL history)
Fresh Supplyfiling state
424B filed ~14d ago

Case Notes

Redhill Biopharma Ltd. has 2 reverse splits on record — cumulative 1-for-894. Its share count grew 294.8% over the last twelve months per XBRL EDGAR data.

No stress-language filings on record in our dataset. However, 6 supply registrations (S-1/424B) appear in the last 12 months.

Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.

Share Count Over Time

XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 2 reverse splits on record.

Reverse Split Log

Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.

2023-03-231-for-32.8
2024-08-201-for-27.2

Cumulative effective ratio: 1-for-894— a share held at inception is now worth 1/894 of its original fraction.

424B Supply Pulse

Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.

01 03 04 08 11 05 11 12 03 04 07 08 10 01 02 04 08 02 07 10 11 02 05 06 07
2021-012021-032021-042021-082021-112022-052022-112022-122023-032023-042023-072023-082023-102024-012024-022024-042024-082025-022025-072025-102025-112026-022026-052026-062026-07

← Back to Registry